These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23332423)

  • 1. Autoimmunity in dengue pathogenesis.
    Wan SW; Lin CF; Yeh TM; Liu CC; Liu HS; Wang S; Ling P; Anderson R; Lei HY; Lin YS
    J Formos Med Assoc; 2013 Jan; 112(1):3-11. PubMed ID: 23332423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current progress in dengue vaccines.
    Wan SW; Lin CF; Wang S; Chen YH; Yeh TM; Liu HS; Anderson R; Lin YS
    J Biomed Sci; 2013 Jun; 20(1):37. PubMed ID: 23758699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune pathogenesis in dengue virus infection.
    Lin CF; Wan SW; Cheng HJ; Lei HY; Lin YS
    Viral Immunol; 2006; 19(2):127-32. PubMed ID: 16817755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis.
    Lin YS; Yeh TM; Lin CF; Wan SW; Chuang YC; Hsu TK; Liu HS; Liu CC; Anderson R; Lei HY
    Exp Biol Med (Maywood); 2011 May; 236(5):515-23. PubMed ID: 21502191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of dengue virus infection.
    Lei HY; Yeh TM; Liu HS; Lin YS; Chen SH; Liu CC
    J Biomed Sci; 2001 Sep; 8(5):377-88. PubMed ID: 11549879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we find a possible structural explanation for antibody-dependent enhancement of dengue virus infection resulting in hemorrhagic fever?
    Mikita CP; Padlan EA
    Med Hypotheses; 2016 Mar; 88():49-52. PubMed ID: 26880637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.
    Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG
    Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage.
    Chao CH; Wu WC; Lai YC; Tsai PJ; Perng GC; Lin YS; Yeh TM
    PLoS Pathog; 2019 Apr; 15(4):e1007625. PubMed ID: 31009511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
    Arévalo MT; Simpson-Haidaris PJ; Kou Z; Schlesinger JJ; Jin X
    J Med Virol; 2009 Mar; 81(3):519-28. PubMed ID: 19152413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in dengue virus pathology.
    Vervaeke P; Vermeire K; Liekens S
    Rev Med Virol; 2015 Jan; 25(1):50-67. PubMed ID: 25430853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection.
    Chuang YC; Lin YS; Liu CC; Liu HS; Liao SH; Shi MD; Lei HY; Yeh TM
    J Formos Med Assoc; 2013 Jan; 112(1):12-7. PubMed ID: 23332424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in dengue vaccine development.
    Wei J; Chen H; An J
    Virol Sin; 2014 Dec; 29(6):353-63. PubMed ID: 25547681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of molecules involved in host immune response to dengue virus infection.
    Fang X; Hu Z; Shang W; Zhu J; Xu C; Rao X
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):134-46. PubMed ID: 22624675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.